Skip to content

    SkinHealth Systems (SKIN) stock price & financials

    View SKIN earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance66.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $78.80M
    $83.50M
    $69.58M
    $78.19M
    $70.66M
    -10.3%
    $82.37M
    -1.3%
    $64.91M
    -6.7%
    $72.11M
    -7.8%
    Weakening
    Operating Profit
    -$21.52M
    -$7.16M
    -$12.02M
    -$2.70M
    -$6.24M
    +71.0%
    $162.0K
    -$1.80M
    +85.0%
    $3.57M
    Strengthening
    Net Profit
    -$18.29M
    -$10.33M
    -$10.10M
    $19.71M
    -$11.03M
    +39.7%
    -$8.10M
    +21.5%
    -$6.63M
    +34.3%
    -$2.67M
    -113.5%
    Weakening
    EPS
    $-0.15
    $-0.08
    $0.16
    $-0.09
    +40.0%
    $-0.05
    +37.5%
    $-0.02
    -112.5%
    Weakening
    Other Income
    Interest
    $2.47M
    $2.46M
    $2.50M
    $4.14M
    $6.31M
    +155.7%
    $6.37M
    +158.7%
    $6.35M
    +154.0%
    $6.29M
    +51.9%
    Strengthening
    Depreciation
    Profit before Tax
    -$16.34M
    -$11.72M
    -$9.20M
    $18.72M
    -$10.64M
    +34.9%
    -$4.81M
    +59.0%
    -$6.81M
    +26.0%
    -$1.46M
    -107.8%
    Weakening
    MarginsOPM
    -27.3%
    -8.6%
    -17.3%
    -3.5%
    -8.8%
    +67.7%
    0.2%
    -2.8%
    +84.0%
    5.0%
    Strengthening
    Tax
    -11.9%
    11.8%
    -9.7%
    -5.3%
    -3.6%
    +69.5%
    -68.5%
    -678.5%
    2.7%
    -82.7%
    -1460.0%
    Weakening
    ReturnsROIC
    3.5%
    2.0%
    1.9%
    -3.7%
    2.1%
    -39.7%
    1.5%
    -21.5%
    1.3%
    -34.3%
    0.5%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$7.31M$9.49M$901.89M$568.20M$523.02M$370.06M$232.67M$206.07M
    Short-Term Investments
    Total Current Assets$59.09M$1.00B$783.27M$698.25M$477.12M$309.52M$295.24M
    Net PP&E$9.19M$31.18M$33.82M$26.35M$19.57M$14.11M$21.48M
    Goodwill$98.52M$98.53M$123.69M$124.59M$125.82M$123.50M$126.62M$126.35M
    Intangibles$50.94M$56.01M$46.39M$62.12M$47.51M$35.76M$30.22M
    Total Assets$222.84M$1.22B$1.00B$929.11M$685.68M$499.80M$486.57M
    LiabilitiesTotal Current Liabilities$30.93M$76.44M$71.71M$115.01M$68.15M$186.28M$168.20M
    Short-Term Debt
    Long-Term Debt$552.20M
    Long-Term Leases$0$12.78M$12.69M$9.32M$10.81M$9.24M$17.98M
    Total Liabilities$252.79M$916.51M$836.03M$869.72M$633.88M$438.75M$431.00M
    EquityCommon Stock & APIC$4.0K$16.0K$14.0K$12.0K$12.0K$13.0K$13.0K
    Retained Earnings-$43.60M-$418.71M-$378.75M-$478.87M-$507.96M-$517.48M-$526.78M
    Total Equity-$1.21M-$30.57M$298.03M$167.05M$59.39M$51.80M$61.06M$55.57M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$1.73M-$12.44M-$28.36M-$106.60M$21.75M$16.13M$37.48M$21.96M
    Cash from Investing-$12.48M-$3.82M-$37.73M-$18.87M-$31.51M-$6.79M-$5.16M-$5.32M
    Cash from Financing$14.58M$18.27M$959.03M-$205.24M-$37.45M-$158.34M-$174.93M-$22.45M
    SummaryCapital Expenditure-$8.77M-$3.50M-$11.20M-$10.85M-$3.83M-$756.0K-$303.0K-$817.0K
    Free Cash Flow-$7.05M-$15.94M-$39.56M-$117.45M$17.93M$15.38M$37.18M$21.14M
    FCF Margin-4.2%-13.4%-15.2%-32.1%4.5%4.6%12.4%7.3%

    Ratios